IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. – IOVA
NEW ORLEANS, Could 28, 2025 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder info service, reminds traders that they’ve till July 15, 2025 to file lead plaintiff purposes in a securities class motion lawsuit towards Iovance Biotherapeutics, Inc. (“Iovance” or the “Firm”) (NasdaqGM: IOVA), in the event that they bought the Firm’s securities between Could 9, 2024 and Could 8, 2025, inclusive (the “Class Interval”). This motion is pending in the US District Court docket for the Northern District of California.
Get Assist
Iovance traders ought to go to us at https://claimsfiler.com/cases/nasdaq-iova/ or name toll-free (844) 367-9658. Legal professionals at Kahn Swick & Foti, LLC can be found to debate your authorized choices.
Concerning the Lawsuit
Iovance and sure of its executives are charged with failing to reveal materials info through the Class Interval, violating federal securities legal guidelines.
On Could 8, 2025, the Firm introduced its 1Q 2025 monetary outcomes, disclosing a quarterly whole product income of $49.3M, a major decline from the prior quarter’s $73.7M, in addition to a 40% lower to its full fiscal yr 2025 whole product income steering from a spread of $450M – $475M to $250M – $300M. Additional, the Firm revealed it was “revising full-year 2025 income steering to replicate latest launch dynamics” of Amtagvi and that “[t]he up to date forecast considers expertise with ATC [authorized treatment center] progress trajectories and remedy timelines for brand spanking new ATCs.”
On this information, the value of Iovance’s shares fell 44.8%, from $1.42 per share to shut at $1.75 per share on Could 9, 2025, on unusually heavy buying and selling quantity.
The case is Farberov v. Iovance Biotherapeutics, Inc., et al., Case No. 25-cv-4199.
About ClaimsFiler
ClaimsFiler has a single mission: to function the data supply to assist retail traders get better their share of billions of {dollars} from securities class motion settlements. At ClaimsFiler.com, traders can: (1) register free of charge to achieve entry to info and settlement web sites for varied securities class motion circumstances to allow them to well timed submit their very own claims; (2) add their portfolio transactional information to be notified about related securities circumstances wherein they might have a monetary curiosity; and (3) submit inquiries to the Kahn Swick & Foti, LLC regulation agency free of charge case evaluations.
To be taught extra about ClaimsFiler, go to http://www.claimsfiler.com.
